Study of Avance eZZe Drink Effects on Improving Sleep Quality in Adults

What this Trial Is About

Researchers are evaluating the effectiveness of Avance eZZe drink with liposomal technology in improving sleep quality. The study aims to compare this drink to an Avance eZZe version without liposomal technology and a placebo. Participants include adults diagnosed with insomnia disorder who also have sleep and stress conditions. This interventional study will measure sleep quality, insomnia severity, and related factors over 28 days. Participants will be randomly assigned to one of three groups Avance eZZe drink with liposomal technology, Avance eZZe drink without liposomal technology, or a placebo drink. Each participant will consume one 25 mL sachet of their assigned sample daily, one hour before bedtime, for 28 days. The study includes multiple assessment points at baseline day 0, day 1, day 14, and day 28 to monitor changes during the intervention. During the study, participants will complete questionnaires assessing sleep disorders and stress conditions and use a sleep monitoring system to track sleep and autonomic nervous system conditions. Researchers will evaluate sleep quality, insomnia severity, daytime sleepiness, depression, anxiety, and autonomic balance using various measures at specified time points. Follow-up visits will ensure adherence and monitor safety throughout the 28-day period.

The Effect of Avnace eZZe on Sleep Improvement